CRS: Whitman-Walker
Position: Pharmacist of Record
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
